Skip to main content
Livermore
Livermore
ZHEN

Grantham, Mayo, Van Otterloo & Co. LLC

SEC CIK
0001352662
Latest filing
Aug 13, 2026

GSK holding history

GSK plc in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
3,599,521
Value
$188.7M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of GSK by Grantham, Mayo, Van Otterloo & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,599,521$188.7M0.4%+76,955+2.2%AddedHolders
Q1 20263,522,566$194.4M0.5%+33,192+1.0%AddedHolders
Q4 20253,489,374$171.1M0.4%+917,248+35.7%AddedHolders
Q3 20252,572,126$111.0M0.3%−29,449−1.1%ReducedHolders
Q2 20252,601,575$99.9M0.3%+460,904+21.5%AddedHolders
Q1 20252,140,671$82.9M0.3%−2,012,945−48.5%ReducedHolders
Q4 20244,153,616$140.5M0.5%+446,568+12.0%AddedHolders
Q3 20243,707,048$151.5M0.5%+561,718+17.9%AddedHolders
Q2 20243,145,330$121.1M0.4%+1,636,365+108.4%AddedHolders
Q1 20241,508,965$64.7M0.2%−169,984−10.1%ReducedHolders
Q4 20231,678,949$62.2M0.3%+412,505+32.6%AddedHolders
Q3 20231,266,444$45.9M0.2%+634,070+100.3%AddedHolders
Q2 2023632,374$22.5M0.1%+473,664+298.4%AddedHolders
Q1 2023158,710$5.65M<0.1%−144,700−47.7%ReducedHolders
Q4 2022303,410$10.7M0.1%−1,837,510−85.8%ReducedHolders
Q3 20222,140,920$63.0M0.4%+192,920+9.9%AddedHolders
Q2 20221,948,000$84.8M0.5%+1,415,300+265.7%AddedHolders
Q1 2022532,700$23.2M0.1%+298,600+127.6%AddedHolders
Q4 2021234,100$10.3M<0.1%−54,800−19.0%ReducedHolders
Q3 2021288,900$11.0M0.1%−304,900−51.3%ReducedHolders
Q2 2021593,800$23.6M0.1%+352,200+145.8%AddedHolders
Q1 2021241,600$8.62M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.